General Wellness: Policy for Low Risk Devices — Guidance for Industry and FDA Staff
Technology context The regulatory boundary between general wellness products and regulated medical devices
Finding: Sets out CDRH’s compliance policy for low-risk products that promote a healthy lifestyle, and clarifies that products intended for maintaining or encouraging a healthy lifestyle and unrelated to diagnosis, cure, mitigation, prevention or treatment of a disease fall outside the device definition.
Main limitation: Guidance documents represent FDA’s current thinking and do not have the force of law; the guidance addresses how a product may be marketed, not whether it works.
Executive summary
If you read one regulatory document before buying wellness equipment, this is the one. It explains why the marketing you encounter is worded the way it is.
The FDA issued this guidance to provide clarity to industry and FDA staff on the Center for Devices and Radiological Health's compliance policy for low-risk products that promote a healthy lifestyle - general wellness products. It does not apply to products regulated by other FDA centres, such as drugs, biologics, dietary supplements, foods or cosmetics, nor to combination products.
The statutory basis is section 3060(a) of the 21st Century Cures Act, which amended section 520 of the Federal Food, Drug, and Cosmetic Act on 13 December 2016. Section 520(o)(1)(B) states that software intended 'for maintaining or encouraging a healthy lifestyle and is unrelated to the diagnosis, cure, mitigation, prevention, or treatment of a disease or condition' is not a device under section 201(h) of the Act. The guidance clarifies FDA's interpretation of that provision and its application to general wellness products.
That single quoted phrase is the hinge on which the entire wellness equipment market turns. A product that stays on the healthy-lifestyle side of it faces a light regulatory touch. A product that makes a disease claim crosses into the medical device pathway, with the evidence requirements that follow.
The guidance notes it does not change or rescind any requirement of the Act or applicable regulations, and does not preclude FDA from consulting the Consumer Product Safety Commission on whether a product is a consumer product or a device.
Why this research matters
Every category in this library - PEMF, red light, molecular hydrogen, advanced wellness - contains products sold under this policy. Understanding it explains why claims are phrased in general wellbeing language and why a manufacturer will not tell you their device treats anything.
It also explains a common misdirection. A device being outside the medical device pathway is sometimes presented as a mark of safety or approval. It means the opposite: no premarket review of safety or effectiveness has occurred, because none was required.
Study design
- Document type
- FDA guidance for industry and FDA staff
- Issuing office
- Center for Devices and Radiological Health (CDRH)
- Docket number
- FDA-2014-N-1039
- Statutory basis
- Section 3060(a) of the 21st Century Cures Act, amending section 520 of the Federal Food, Drug, and Cosmetic Act on 13 December 2016
- Key provision
- Section 520(o)(1)(B) of the FD&C Act
- Scope
- Low-risk products that promote a healthy lifestyle (general wellness products)
- Explicit exclusions
- Products regulated by other FDA centres - drugs, biologics, dietary supplements, foods, cosmetics - and combination products
- Legal effect
- Guidance; does not change or rescind requirements of the Act or applicable regulations
- Study design, sample, outcomes
- Not applicable - this is regulatory guidance, not research
What the researchers found
The guidance provides clarity on CDRH's compliance policy for low-risk products that promote a healthy lifestyle.
It rests on section 520(o)(1)(B) of the FD&C Act, which states that software intended 'for maintaining or encouraging a healthy lifestyle and is unrelated to the diagnosis, cure, mitigation, prevention, or treatment of a disease or condition' is not a device under section 201(h) of the Act. The guidance clarifies FDA's interpretation of this provision and its application to general wellness products.
It states that it does not apply to products regulated by other FDA centres or to combination products, does not change or rescind any requirements of the Act or applicable regulations, and does not preclude FDA from consulting the Consumer Product Safety Commission as to whether a general wellness product is a consumer product under CPSC's authority or a device.
No study data, effect sizes, or statistical measures exist in this document, and none are reproduced here.
What the results mean
The practical consequence is a vocabulary and a boundary.
On the wellness side of the boundary, a product may describe general wellbeing, relaxation, fitness, sleep quality or similar, provided it does not relate to diagnosing, curing, mitigating, preventing or treating a disease or condition. On the other side, any such claim brings the product into the device pathway with its evidence requirements.
This is why a PEMF mat is sold for general wellbeing while a bone growth stimulator is prescribed for a fracture, even though both use pulsed electromagnetic fields. It is a regulatory distinction with real consequences for what evidence exists behind each.
It also clarifies the terminology. 'Approved', 'cleared', 'registered' and 'listed' describe four different things, and only the first two involve any FDA review.
What this study does not prove
- It does not establish that any general wellness product is effective. It is a compliance policy, not evidence.
- It does not establish that general wellness products are safe; low-risk classification is not the same as demonstrated safety.
- It does not have the force of law and does not create binding obligations.
- It does not apply to drugs, biologics, dietary supplements, foods, cosmetics, or combination products.
- It does not adjudicate any specific product's classification, which depends on the intended use and claims made.
- It does not evaluate any technology discussed elsewhere in this library.
Evidence strength
Regulatory guidance
FDA guidance documents state the agency's current thinking on a topic. They do not have the force of law and do not create binding obligations, but they describe how the agency intends to apply the statute - which in practice shapes what manufacturers can say.
This one is a compliance policy rather than a scientific document. It contains no evidence about whether any technology works.
Strengths and limitations
Strengths
- Primary source from the regulator responsible for the device category.
- Directly quotes the statutory provision it interprets.
- Clear scope statement and explicit exclusions.
- Publicly accessible with a docket number for verification.
- Explains a boundary that determines what evidence is required of a product.
Limitations
- Guidance rather than binding law.
- Addresses marketing and regulatory classification, not efficacy.
- Classification depends on intended use and claims, which are determined by the manufacturer in the first instance.
- Contains no scientific evidence about any technology.
- Not written for consumers; the language is regulatory.
Does this apply to the equipment IMPERVITA sells?
This applies across most of the IMPERVITA range. PEMF mats, red light panels, molecular hydrogen equipment and the emerging technologies grouped under advanced wellness are generally sold as general wellness products under this policy.
The practical application is to read claims against the boundary. A product described as supporting general wellbeing, relaxation or recovery is operating within the policy. A product described as treating, curing, preventing or mitigating a condition has made a disease claim, and you are entitled to ask what clearance supports it.
IMPERVITA is a retailer and equipment advisor. We do not diagnose, treat, or provide medical services, and we write product content to stay firmly on the general wellness side of this boundary.
Evidence in context
This guidance works alongside the FTC's health products compliance guidance, which governs advertising substantiation. FDA determines whether a product is a regulated device; FTC determines whether the claims made about it are adequately supported. A product can be entirely lawful as a general wellness device and still be advertised unlawfully.
The distinction it draws is directly relevant to several entries in this library. PEMF fracture-healing trials used cleared medical devices; PEMF wellness mats are general wellness products. Hyperbaric chambers are Class II medical devices; lower-pressure wellness chambers are marketed differently.
No superseding guidance has been issued as far as we are aware.
Related research
- Health products compliance guidance The advertising substantiation standard that operates alongside this classification framework.
- Effectiveness of pulsed electromagnetic fields on bone healing: a systematic review and meta-analysis of randomized controlled trials PEMF fracture-healing evidence from cleared medical devices - the contrast that makes this boundary concrete.
- 21 CFR 868.5470 - Hyperbaric chamber Federal classification of the hyperbaric chamber as a Class II medical device.
- Photobiomodulation: a review of the molecular evidence for low level light therapy Notes the absence of regulatory standards in photobiomodulation, a related gap.
Practical buyer relevance
This entry gives you the four words that matter and what each one means.
Approved means premarket approval, the most demanding pathway, used mainly for Class III devices. Cleared means 510(k) premarket notification, in which substantial equivalence to a predicate device was demonstrated. Registered means the manufacturer completed establishment registration. Listed means the device was entered in the device listing. Only the first two involve FDA review of the device itself.
Ask any seller in the PEMF, red light or hydrogen categories a single question in writing: is this an FDA-cleared medical device or a general wellness product? Both answers are legitimate. What is not legitimate is blurring them, and how a seller handles that question tells you how carefully they read their own documentation.
Safety context
Classification as a low-risk general wellness product is not a finding of safety. It reflects that the product does not make disease claims and is considered low risk, not that it has undergone premarket safety review.
Manufacturer contraindication lists remain the relevant safety document for any specific product. People with implanted electronic devices, chronic health conditions, or who are pregnant may require guidance from a qualified healthcare professional before using wellness equipment.
Full source record
- Title
- General Wellness: Policy for Low Risk Devices — Guidance for Industry and FDA Staff
- Authors
- U.S. Food and Drug Administration, Center for Devices and Radiological Health
- Organization
- U.S. FDA, Center for Devices and Radiological Health
- Publication
- FDA Guidance Documents
- Year
- 2019
- Volume / issue / pages
- Docket number FDA-2014-N-1039
- Study type
- FDA guidance for industry and FDA staff
- Sample size
- Not applicable
- Population
- Not applicable
- Topic
- Molecular Hydrogen, PEMF, Red Light, regulatory, Safety
- Document type
- Regulatory guidance
- Technology context
- The regulatory boundary between general wellness products and regulated medical devices
- Related equipment context
- PEMF, Red Light Therapy, Molecular Hydrogen, Advanced Wellness
- Source last verified
- 19 August 2026
References
- General wellness: policy for low risk devices - guidance for industry and FDA staff
- Health products compliance guidance
- 21 CFR 868.5470 - Hyperbaric chamber
- Effectiveness of pulsed electromagnetic fields on bone healing: a systematic review and meta-analysis of randomized controlled trials
- Photobiomodulation: a review of the molecular evidence for low level light therapy
Information provided by IMPERVITA is for educational and general wellness purposes and is not intended to replace professional medical advice, diagnosis, or treatment.
